DalsnaFinance

Selagine Plasma to Advance Pooled Plasma Eye Drops for Moderate-to-Severe Dry Eye

Markets PR Newswire By PR Newswire 09 Jun 2026 12:08 1 min read
Selagine Plasma to Advance Pooled Plasma Eye Drops for Moderate-to-Severe Dry Eye

Agreement with Selagine, Inc. supports the development of an investigational pooled plasma biologic platform intended to move beyond individualized compounded serum tears CHICAGO, June 9, 2026 /PRNewswire/ -- Selagine Plasma, Inc. announced that it has received certain intellectual...

Agreement with Selagine, Inc. supports the development of an investigational pooled plasma biologic platform intended to move beyond individualized compounded serum tears CHICAGO, June 9, 2026 /PRNewswire/ -- Selagine Plasma, Inc. announced that it has received certain intellectual...

Read the full story on PR Newswire → Opens the original article on www.prnewswire.com

Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.